A device that permits the rerouting of blood flow during surgery to treat a brain aneurysm or tumor in people at greater risk of stroke has been approved by the US Food and Drug Administration (FDA).

The Excimer Laser Assisted Non-Occlusive Anastamosis (ELANA) Surgical Kit makes it possible for surgeons to bypass the aneurysm or tumor without clipping the affected artery and temporarily ending blood flow, the agency said in a news release.


About 1,000 people who have brain bypass surgery each year would be at higher-than-normal risk of stroke if the artery were clipped and blood flow stopped, the agency said. These patients-13 and older-often have a weakened, enlarged area in a brain artery called a cerebral aneurysm, or a tumor at the base of the skull.

Not For Patients With Hardening Of Arteries

The ELANA kit should not be used if the patient shows hardening of the arteries (arteriosclerosis) or artery calcification, the FDA warned.

The device is made by Elana, based in the Netherlands.

Want to Keep Reading?

Continue reading with a Health Confidential membership.

Sign up now Already have an account? Sign in